Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity

Molecular Endocrinology

Volumn 13, Issue 4, 1999, Pages 537-545

  He, Yulong ^a   Smith, Stephen K ^a   Day, Kate A ^a   Clark, Dawn E ^a   Licence, Diana R ^a   Charnock Jones, D Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DNA SEQUENCE; EMBRYO; FEMALE; FIBRIN DEPOSITION; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA FUNCTION; PREGNANCY; PRIORITY JOURNAL;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0033334764     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.4.0265     Document Type: Article

References (41)

1. Angiogenesis
2. Angiogenesis in cancer, vascular, rheumatoid and other disease
3. Angiogenesis in the human female reproductive tract
4. Ultrastructural differentiation of stromal and vascular components in early macaque placental villi
5. In situ detection of basic fibroblast growth factor by highly specific antibodies
6. Evidence of high and low affinity binding sites for basic fibroblast growth factor in mouse placenta
7. Colocalization of acidic and basic fibroblast growth factor in human placenta and the cellular effects of bFGF in trophoblast cell
8. Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, an high affinity binding to Flt-1 but not to Flk-1/KDR
9. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry
10. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development
11. Vascularization of the mouse embryo: A study of flk-1 ,tek, tie, and vascular endothelial growth factor expression during development
12. Expression of the vascular endothelial growth factor receptor, KDR, in human placenta
13. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy
14. Angiogenesis and the placental environment
15. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up- regulated by hypoxia
16. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation
17. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
18. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein
19. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
20. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
21. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
22. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
23. Vascular permeability factor, an endothelial cell mitogen related to PDGF
24. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
25. Human vascular permeability factor. Isolation from U937 cells
26. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
27. Identification of natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR
28. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
29. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
30. Vascular endothelial growth factor receptor localisation and activation in human trophoblast and choriocarcinoma cells
31. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy
32. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins
33. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
34. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placental growth factor in monocyte activation and chemotaxis
35. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
36. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization
37. Studies on the character and staining of fibrin
38. Single step method of RNA isolation by guanidine thiocyanate-phenol-chloroform extraction
39. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer
40. Molecular cloning of murine FLT and FLT4
41. Fibroblast growth factor-2 (FGF-2) is present in maternal and cord serum, and in the mother is associated with a binding protein immunologically related to the FGF receptor-1